Sunscreen and SPF Packaging Requirements: FDA OTC Monograph, EU Cosmetic Rules, and What Your Label Must Say

Sunscreen is one of the most regulatory-intensive product categories in personal care. In the United States, sunscreen is regulated as an over-the-counter (OTC) drug — not as a cosmetic — under the FDA's OTC drug monograph system. This means sunscreen packaging must meet OTC drug labelling requirements, not cosmetic labelling requirements. In the European Union and United Kingdom, sunscreen is regulated as a cosmetic, with additional guidance from the EU Cosmetics Regulation and the COLIPA (now Cosmetics Europe) voluntary labelling recommendations.

The practical consequence is that a sunscreen brand selling in both the US and EU cannot use the same label in both markets — the required information, the required format, and the regulatory framework are fundamentally different.

US: Sunscreen as an OTC Drug

The Regulatory Framework

The FDA regulates sunscreen products (products intended to protect skin from UV radiation) as OTC drugs under 21 CFR Parts 201 and 352. The OTC Final Monograph for sunscreen (published in stages from 1978 to 2020) specifies which active ingredients are permitted, at what concentrations, and how they must be labelled.

The Sunscreen Innovation Act (2014) and the ongoing Over-the-Counter Monograph Reform process (MoCRA framework for OTC drugs) have updated the regulatory framework. As of the current status, many sunscreen active ingredient applications remain pending final FDA determination — the category is in active regulatory evolution.

Permitted Active Ingredients

Only FDA-monograph-approved active ingredients are permitted in OTC sunscreen sold in the US. The currently permitted ingredients include:

• Zinc oxide (up to 25%) — allowed
• Titanium dioxide (up to 25%) — allowed
• Avobenzone (up to 3%) — allowed
• Octinoxate (octyl methoxycinnamate) (up to 7.5%) — allowed
• Oxybenzone (up to 6%) — allowed (but banned in Hawaii and some other jurisdictions for environmental reasons)
• Several other traditional chemical filters — allowed at specified maximums

Notably not approved for US OTC use: Many European UV filters (Tinosorb M, Tinosorb S, Mexoryl SX, Mexoryl XL, Bemotrizinol, Bisoctrizole) that are approved in the EU are not yet approved for US OTC sunscreen. Sunscreen products formulated with these ingredients cannot be sold as sunscreen in the US.

Required Label Elements for US OTC Sunscreen

Drug Facts panel. All OTC drugs in the US must carry a Drug Facts panel in the format specified by 21 CFR 201.66. For sunscreen, the Drug Facts panel must include:

• Active ingredient(s): Name and concentration of each sunscreen active, followed by "(sunscreen)"
• Purpose: "Sunscreen"
• Uses: The specific uses for which the product is indicated — must include language from the FDA-approved use statements ("helps prevent sunburn" is mandatory; optional additions include "if used as directed with other sun protection measures, decreases the risk of skin cancer and early skin aging caused by the sun")
• Warnings:
  • "Skin cancer/skin aging alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging."
  • "Do not use on damaged or broken skin"
  • "When using this product keep out of eyes"
  • "Stop use and ask a doctor if rash occurs"
  • "Keep out of reach of children" (with poison control number for US products)
• Directions:
  • "Apply liberally 15 minutes before sun exposure"
  • SPF-specific directions for water resistance, reapplication frequency, and children
• Inactive ingredients: The non-active cosmetic ingredients, in descending order (the INCI list for the cosmetic base)
• Other information: May include storage instructions, lot number, expiry date

SPF number. The SPF (Sun Protection Factor) number must appear on the principal display panel (PDP) — the front panel. The FDA requires that the SPF number be expressed as "SPF [number]" (for example, "SPF 30") and that the SPF number be accurate as determined by the FDA-prescribed SPF test method.

Broad Spectrum claim. If the product has passed the FDA Critical Wavelength test (demonstrating protection across both UVA and UVB), it may display "Broad Spectrum SPF [number]" on the PDP. Products with SPF 15 or above that are Broad Spectrum may claim to help reduce the risk of skin cancer and early skin aging. Products with SPF below 15, or non-Broad Spectrum products at any SPF, may only claim to help prevent sunburn.

Water resistance claim. If the product is water resistant, the PDP must state either "Water Resistant (40 minutes)" or "Water Resistant (80 minutes)" — the specific duration as determined by the FDA water resistance test. No other water resistance claims are permitted — "waterproof," "sweatproof," or "all-day protection" are prohibited terms.

PDP requirements summary. The PDP of a US OTC sunscreen must include: product name, SPF number (or Broad Spectrum SPF number), water resistance time (if applicable), and net quantity.

Drug Facts Panel Format

The Drug Facts panel has a prescribed visual format specified in 21 CFR 201.66:

• A rectangular box bordered by a hairline rule
• The words "Drug Facts" in bold at the top, flush left
• Text formatted in two columns for most sections
• Minimum 6pt type for most text; headings in bold
• The panel must be "placed prominently on the label" — typically on the back or side panel

EU: Sunscreen as a Cosmetic

The Regulatory Framework

In the EU (and post-Brexit UK, which retains equivalent cosmetic regulation), sunscreen is regulated as a cosmetic under Regulation (EC) 1223/2009. There is no OTC drug category for sunscreen in the EU — sunscreen active ingredients are permitted cosmetic ingredients listed in Annex VI of the Cosmetics Regulation (UV filters), each with specified maximum concentrations.

EU Permitted UV Filters

The EU permitted UV filter list (Annex VI) is more extensive than the US monograph. It includes many chemical UV filters not approved in the US (Tinosorb, Mexoryl variants, Uvinul filters) as well as Zinc Oxide and Titanium Dioxide at specified concentrations (which may differ from US maximums).

Required Label Elements for EU Sunscreen

EU sunscreen packaging must carry all standard cosmetic label elements (see the EU Cosmetics Regulation section of the broader cosmetics labelling guide), plus:

SPF claim. The EU Cosmetics Regulation does not specify a mandatory SPF declaration format, but Cosmetics Europe (formerly COLIPA) guidance (2006, revised 2019) recommends that SPF claims be based on the ISO 24444 test method and that SPFs be declared in the categories: SPF 6, 10, 15, 20, 25, 30, 50, 50+. SPF values above 50 are declared as "50+" per the recommendation — there is no "SPF 75" or "SPF 100" labelling in the EU.

UVA claim. The EU recommendation is that products making a UVA protection claim must pass the ISO 24442 in-vitro test or equivalent, with a UVA protection factor that is at least one-third of the SPF. A product may carry the UVA logo (a circle containing "UVA") if it meets this standard.

Category claims. Cosmetics Europe recommends standardised sun protection category labelling:

• SPF 6–10: "Low protection"
• SPF 15–25: "Medium protection"
• SPF 30–50: "High protection"
• SPF 50+: "Very high protection"

These category descriptors are voluntary but widely used.

Required warnings (EU):

• "Keep babies and children out of direct sunlight"
• "Do not stay too long in the sun, even if you use a sunscreen"
• "Over-exposure to the sun is a serious health risk"

Key Differences: US vs EU Sunscreen Labels

Practical Implications for Multi-Market SPF Products

A brand selling sunscreen in both the US and EU cannot use a single label:

1. The active ingredients may differ — EU formulations often use EU-only UV filters not approved in the US
2. The US label must carry a Drug Facts panel; the EU label does not
3. The SPF cap (50+ in EU) means a US "SPF 70" product must be relabelled as "SPF 50+" for EU sale
4. The water resistance wording is different
5. The EU label must carry a UK/EU Responsible Person; the US label must carry the manufacturer's US address

Brands entering both markets typically maintain separate formulations and separate label artwork for US and EU markets.

FAQ

Does my moisturiser with SPF 15 need a Drug Facts panel in the US? Yes. Any product that claims SPF protection in the US is regulated as an OTC drug, regardless of whether it is primarily marketed as a moisturiser, foundation, lip balm, or body oil. All SPF-claiming products sold in the US must carry a Drug Facts panel compliant with 21 CFR 201.66.

Can I claim SPF on a tinted moisturiser in the EU? Yes — the EU treats all SPF-claiming products as cosmetics. A tinted moisturiser with Zinc Oxide at a compliant concentration, tested to ISO 24444 for SPF, may carry an SPF claim under EU cosmetic labelling requirements without a Drug Facts panel.

What happens if a US sunscreen product's Drug Facts panel is non-compliant? The FDA may issue a Warning Letter, require reformulation of the label, or pursue enforcement action for products misbranded under the Federal Food, Drug, and Cosmetic Act. Retailers may de-list non-compliant OTC drug products. For SPF claims specifically, the FTC may also take action under its guidelines on advertising substantiation.